Ligand Pharmaceuticals (LGND) Stock Dips While Market Gains: Key Facts [Yahoo! Finance]
Ligand Pharmaceuticals Incorporated (LGND)
Last ligand pharmaceuticals incorporated earnings: 2/6 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.ligand.com
Company Research
Source: Yahoo! Finance
This move lagged the S&P 500's daily gain of 1.11%. At the same time, the Dow added 0.8%, and the tech-heavy Nasdaq gained 1.24%. The drugmaker's stock has climbed by 7.6% in the past month, exceeding the Medical sector's loss of 2.46% and the S&P 500's gain of 0.48%. Market participants will be closely following the financial results of Ligand Pharmaceuticals in its upcoming release. The company is expected to report EPS of $1.13, down 50.44% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $32.5 million, reflecting a 26.1% fall from the equivalent quarter last year. For the annual period, the Zacks Consensus Estimates anticipate earnings of $4.56 per share and a revenue of $139.25 million, signifying shifts of +12.32% and +6.04%, respectively, from the last year. It is also important to note the recent changes to analyst estimates for Ligand Pharmaceuticals. Recent revisions tend to reflect the latest near-term busi
Show less
Read more
Impact Snapshot
Event Time:
LGND
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LGND alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LGND alerts
High impacting Ligand Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
LGND
News
- Can Mixed Fundamentals Have A Negative Impact on Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Current Share Price Momentum? [Yahoo! Finance]Yahoo! Finance
- Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy [Yahoo! Finance]Yahoo! Finance
- Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA NephropathyBusiness Wire
- Travere gains on full FDA approval for kidney drug Filspari [Seeking Alpha]Seeking Alpha
- Ligand to Present at H.C. Wainwright 26th Annual Global Investment ConferenceBusiness Wire
LGND
Earnings
- 8/6/24 - Beat
LGND
Sec Filings
- 9/25/24 - Form 4
- 9/24/24 - Form 4
- 9/24/24 - Form 4
- LGND's page on the SEC website